Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 12,840 shares, a decrease of 42.1% from the August 31st total of 22,195 shares. Based on an average daily volume of 92,879 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.3% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, September 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Mannatech presently has a consensus rating of “Sell”.
Check Out Our Latest Analysis on Mannatech
Mannatech Stock Down 2.5%
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Wednesday, August 12th. The company reported $0.53 earnings per share (EPS) for the quarter. The company had revenue of $26.65 million for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 6.90%.
About Mannatech
Mannatech, Incorporated (NASDAQ: MTEX) develops and sells nutritional supplements, functional foods and personal-care products. Its offerings are designed to support areas such as general wellness, nutrition, energy and skincare, and include supplement powders, capsules, beverages and topical products.
The company primarily uses a direct-selling business model, marketing its products through independent associates and distributors as well as through online channels. Mannatech is known for products incorporating plant-based and other nutritional ingredients, including its Ambrotose and MannaBears product lines.
Founded in 1994, Mannatech is based in Flower Mound, Texas.
Featured Stories
- Five stocks we like better than Mannatech
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
